朝聚眼科医疗控股有限公司（02219）于2025年12月29日发布翌日披露报表，宣布当日回购普通股股份10万股。该次回购的每股价格介乎每股2.66港元至2.71港元，涉资约27万港元。回购后，公司于期末的已发行股本仍为707,510,500股（不包括库藏股），未有新增或注销股份记录。
公司回购授权于2025年6月6日经股东大会通过，总额度为可回购70,751,050股。截至本次回购，公司合计已回购1,660,000股，占授权通过当日已发行股本约0.23%。公司确认上述回购符合香港联交所上市规则及相关法律法规规定。公告由执行董事兼联席公司秘书张光弟签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.